Links to all GeneRIF Items | 1485 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 16140944 (CTAG1B) | Data indicate that reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter mediates epigenetic regulation of this CT gene in lung cancer cells. |
| 18982744 (CTAG1B) | Its expression is significantly associated with prognostic factors in poor outcome of the non-small cell lung cancer. |
| 19795170 (CTAG1B) | MAGE-A3/6 and NY-ESO-1 were expressed in 50.0% (66/132) and 18.2% (24/132) of non-small-cell lung carcinomas, respectively. |
| 23645764 (CTAG1B) | High CTAG1 expression and down-regulation of HLA class-I is associated with non-small cell lung cancer. |
| 26191258 (CTAG1B) | CTAs (MAGE-A4, NY-ESO-1, MAGE-A10) were more likely expressed in patients with squamous cell carcinoma of the lung and when CTAs combined with CD133, they can be better prognostic factors. |
| 26324743 (CTAG1B) | These cells were used to target a human lung cancer line that expressed NY-ESO-1. |
| 27793776 (CTAG1B) | High NY-ESO-1 expression is associated with lung cancer. |
| 30953385 (CTAG1B) | High NY-ESO-1 expression is associated with non-small cell lung cancer metastasis. |